The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination

Abstract Background Despite significant advancements in therapeutic approaches for lung cancer, the prognosis of lung squamous cell carcinoma (LUSC) remains suboptimal, underscoring the critical need to identify novel molecular targets and develop targeted therapeutic strategies. Through bioinformat...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Yang, Zhongfei Jia, Juan Li, Chao Jiang, Xin Zhao, Yuxiang Wang, Xiaoguo Ma, Xinjian Xu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Biology Direct
Subjects:
Online Access:https://doi.org/10.1186/s13062-025-00677-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237637018157056
author Jie Yang
Zhongfei Jia
Juan Li
Chao Jiang
Xin Zhao
Yuxiang Wang
Xiaoguo Ma
Xinjian Xu
author_facet Jie Yang
Zhongfei Jia
Juan Li
Chao Jiang
Xin Zhao
Yuxiang Wang
Xiaoguo Ma
Xinjian Xu
author_sort Jie Yang
collection DOAJ
description Abstract Background Despite significant advancements in therapeutic approaches for lung cancer, the prognosis of lung squamous cell carcinoma (LUSC) remains suboptimal, underscoring the critical need to identify novel molecular targets and develop targeted therapeutic strategies. Through bioinformatic analysis, SH3RF2 was identified as a gene significantly upregulated in LUSC patients, and its high expression was strongly associated with lower survival rates. However, no significant differences in expression or survival correlation were observed in lung adenocarcinoma. Notably, SH3RF2, an E3 ubiquitin ligase characterized by three SH3 domains, has not been systematically investigated in LUSC pathogenesis. Results Mechanistic investigations found that SH3RF2 promoted tumor cell proliferation, upregulated M2 markers (Arg-1, CD163, IL-10), increased CD206 + subpopulation of M0 THP-1 cells and enhanced migration and invasion of M0 THP-1 cells. SH3RF2 promoted the nuclear translocation of β-catenin. Furthermore, ICG-001, the inhibitors of β-catenin pathway, alleviated the above effects of SH3RF2. In vivo tumorigenesis experiments found that SH3RF2 promoted tumor growth and increased the proportion of M2 cells. Proteomic analysis revealed that SH3RF2 interacted with LZTS2 and regulated the ubiquitination of LZTS2 with RING domain. Overexpression of LZTS2 attenuated SH3RF2-induced nuclear translocation of β-catenin, suppressed cellular migration and invasion, and inhibited M2 polarization promoted by SH3RF2 overexpression. The combination of SH3RF2 knockdown and radiotherapy inhibited the growth of tumor compared with SH3RF2 knockdown or radiotherapy alone. Conclusions This study demonstrates the functionality of SH3RF2 in both potentiating tumor progression and inducing M2 macrophage polarization through coordinated regulation of LZTS2 degradation and β-catenin nuclear translocation. These findings establish a novel mechanistic framework and propose SH3RF2-associated signaling axes as promising therapeutic targets for LUSC.
format Article
id doaj-art-c4d9ebd69f044c008523751f9ad5d654
institution Kabale University
issn 1745-6150
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Biology Direct
spelling doaj-art-c4d9ebd69f044c008523751f9ad5d6542025-08-20T04:01:53ZengBMCBiology Direct1745-61502025-07-0120111510.1186/s13062-025-00677-0The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitinationJie Yang0Zhongfei Jia1Juan Li2Chao Jiang3Xin Zhao4Yuxiang Wang5Xiaoguo Ma6Xinjian Xu7Department of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityDepartment of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityDepartment of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityDepartment of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityClinical College of Hebei Medical UniversityDepartment of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityDepartment of Radiotherapy, The Fourth Hospital of Hebei Medical UniversityDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical UniversityAbstract Background Despite significant advancements in therapeutic approaches for lung cancer, the prognosis of lung squamous cell carcinoma (LUSC) remains suboptimal, underscoring the critical need to identify novel molecular targets and develop targeted therapeutic strategies. Through bioinformatic analysis, SH3RF2 was identified as a gene significantly upregulated in LUSC patients, and its high expression was strongly associated with lower survival rates. However, no significant differences in expression or survival correlation were observed in lung adenocarcinoma. Notably, SH3RF2, an E3 ubiquitin ligase characterized by three SH3 domains, has not been systematically investigated in LUSC pathogenesis. Results Mechanistic investigations found that SH3RF2 promoted tumor cell proliferation, upregulated M2 markers (Arg-1, CD163, IL-10), increased CD206 + subpopulation of M0 THP-1 cells and enhanced migration and invasion of M0 THP-1 cells. SH3RF2 promoted the nuclear translocation of β-catenin. Furthermore, ICG-001, the inhibitors of β-catenin pathway, alleviated the above effects of SH3RF2. In vivo tumorigenesis experiments found that SH3RF2 promoted tumor growth and increased the proportion of M2 cells. Proteomic analysis revealed that SH3RF2 interacted with LZTS2 and regulated the ubiquitination of LZTS2 with RING domain. Overexpression of LZTS2 attenuated SH3RF2-induced nuclear translocation of β-catenin, suppressed cellular migration and invasion, and inhibited M2 polarization promoted by SH3RF2 overexpression. The combination of SH3RF2 knockdown and radiotherapy inhibited the growth of tumor compared with SH3RF2 knockdown or radiotherapy alone. Conclusions This study demonstrates the functionality of SH3RF2 in both potentiating tumor progression and inducing M2 macrophage polarization through coordinated regulation of LZTS2 degradation and β-catenin nuclear translocation. These findings establish a novel mechanistic framework and propose SH3RF2-associated signaling axes as promising therapeutic targets for LUSC.https://doi.org/10.1186/s13062-025-00677-0Lung squamous cell carcinomaSH3RF2LZTS2Β-cateninM2 polarization
spellingShingle Jie Yang
Zhongfei Jia
Juan Li
Chao Jiang
Xin Zhao
Yuxiang Wang
Xiaoguo Ma
Xinjian Xu
The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
Biology Direct
Lung squamous cell carcinoma
SH3RF2
LZTS2
Β-catenin
M2 polarization
title The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
title_full The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
title_fullStr The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
title_full_unstemmed The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
title_short The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination
title_sort role of sh3rf2 in lung squamous cell carcinoma and m2 polarization insights into lzts2 ubiquitination
topic Lung squamous cell carcinoma
SH3RF2
LZTS2
Β-catenin
M2 polarization
url https://doi.org/10.1186/s13062-025-00677-0
work_keys_str_mv AT jieyang theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT zhongfeijia theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT juanli theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT chaojiang theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xinzhao theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT yuxiangwang theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xiaoguoma theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xinjianxu theroleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT jieyang roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT zhongfeijia roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT juanli roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT chaojiang roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xinzhao roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT yuxiangwang roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xiaoguoma roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination
AT xinjianxu roleofsh3rf2inlungsquamouscellcarcinomaandm2polarizationinsightsintolzts2ubiquitination